Revised 2012 FDA Electoral Fairness Report on the United States

us capitolReport revised as of April 11, 2013. Revision number 1.

Executive Summary

The American federal electoral system borders a failed state as determined by the overall unsatisfactory audit score of 54.5 percent (out of 100 percent). The FDA auditors measured

  1. two failing scores for legislation pertaining to electoral finance (48.25 percent) and media election content (42.5 percent);
  2. one unsatisfactory score for legislation pertaining to candidates and parties (57 percent);
  3. one satisfactory score for legislation pertaining to voters (70.25 percent).

The FDA auditors factored in 52 independent variables and used matrices and financial spreadsheets in its calculations and determinations. Based on its measurements, the FDA believes that the American federal election outcomes may not reflect the voice of Americans from electoral districts. The significant legislated unfair competition between American candidates and parties coupled with electoral finance legislation favoring wealthy money interests and media legislation favoring large corporate media and imbalanced election coverage creates a system tilted heavily to special and minority interests, rather than the American people. The FDA believes that reforms are necessary in electoral finance and election coverage in order to help realign the American federal electoral process with Americans as a whole. The FDA recommends, for examples, expenditure limits on congressional candidates and privately funded presidential candidates, caps on independent third-party expenditure, caps on media ownership concentration, and a voluntary media code of conduct during the 60 day campaign period which supports impartial and balanced campaign coverage of all registered candidates and parties.

The FDA recommends that the public get involved with the government legislative process and implementation if they want to protect and advance their democratic voice, and create a society of their choosing.

Downloadable Revised 2012 FDA Report on the United States

FDA Media Advisory on the USA